{"id":"W2752563952","doi":"10.1200/jco.2017.73.3246","title":"First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"ca_institutions":"Seagen (Canada)","funders":"National Cancer Institute; Pfizer; Eli Lilly and Company","keywords":"Medicine; Tamoxifen; Fulvestrant; Internal medicine; Metastatic breast cancer; Breast cancer; Oncology; Pharmacokinetics; Cancer; Gastroenterology; Pharmacology; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001177803,0.0009743428,0.001461242,0.0002659208,0.0003551087,0.0005004503,0.0004658123,0.0006328697,0.002443891],"category_scores_gemma":[0.0006658374,0.0004592105,0.0006501789,0.0002249035,0.0007310023,0.0004598677,0.0002393085,0.001638671,0.0005328714],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006028595,"about_ca_system_score_gemma":0.001118389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006323225,"about_ca_topic_score_gemma":0.002184074,"domain_scores_codex":[0.999642,0.0001893921,0.00001391395,0.00005089608,0.00003077415,0.00007295633],"domain_scores_gemma":[0.9995632,0.00007507236,0.00007016872,0.00004268793,0.00002693563,0.0002219712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.468256,0.1027191,0.02393642,0.001589839,0.001501928,0.001331237,0.0007293491,0.003258871,0.2191192,0.0004874482,0.007164401,0.1699062],"study_design_scores_gemma":[0.2451831,0.7130904,0.02005298,0.0000350372,0.0004583079,0.0007556177,0.0001033416,0.0009683535,0.01249059,0.0002578484,0.006577881,0.00002671122],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906579,0.00247541,0.0009216385,0.0004808696,0.00009316597,0.002966754,0.0008876016,0.00007631694,0.001440279],"genre_scores_gemma":[0.9893791,0.001933327,0.001704459,0.0007641862,0.0001421214,0.002110257,0.001133099,0.0000266129,0.002806866],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002443891,"threshold_uncertainty_score":0.008175611,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1239145229701659,"score_gpt":0.5287560360576353,"score_spread":0.4048415130874694,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}